Verastem
VSTM
78 hedge funds and large institutions have $44.4M invested in Verastem in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 22 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.36% less ownership
Funds ownership: 2.8% → 2.44% (-0.36%)
11% less funds holding
Funds holding: 88 → 78 (-10)
13% less capital invested
Capital invested by funds: $50.8M → $44.4M (-$6.43M)
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
86% less call options, than puts
Call options by funds: $64K | Put options by funds: $462K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.57M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.41M |
| 3 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$1.29M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$888K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$884K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$3.07M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$1.67M |
| 3 |
AIC
AWM Investment Company
New York
|
-$1.41M |
| 4 |
Renaissance Technologies
New York
|
-$1.08M |
| 5 |
Two Sigma Investments
New York
|
-$804K |
VSTM Hedge Fund Activity: Q1 2018 in Review
78 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q1 2018, worth a combined $44.4M — down 13% from $50.8M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of VSTM and 13 opened new positions — a net loss of 9 holders — while 22 trimmed existing stakes and 28 added.
The largest buyer was BVF Inc, adding an estimated $1.57M. The largest seller was Artal Group, exiting entirely with an estimated $3.07M sold.
- 78 institutional investors held Verastem (VSTM) as of Q1 2018, down from 88 in Q4 2017.
- Funds reported $44.4M of Verastem stock for Q1 2018, down 13% quarter-over-quarter.
- 13 funds opened new Verastem positions in Q1 2018 and 22 closed out, a net change of -9 holders.
- The largest Verastem buyer in Q1 2018 was BVF Inc, an estimated $1.57M added.
- The largest Verastem seller in Q1 2018 was Artal Group, an estimated $3.07M sold.
Based on aggregated 13F filings for Q1 2018.